MCID: BCT007
MIFTS: 61

Bacterial Meningitis

Categories: Infectious diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Bacterial Meningitis

MalaCards integrated aliases for Bacterial Meningitis:

Name: Bacterial Meningitis 12 77 54 3 15 17
Meningitis, Bacterial 54 45 74
Meningitis Bacterial 56

Classifications:



External Ids:

Disease Ontology 12 DOID:9470
ICD9CM 36 320 320.9
MeSH 45 D016920
NCIt 51 C118297
SNOMED-CT 69 95883001
ICD10 34 G00 G00.9
UMLS 74 C0085437

Summaries for Bacterial Meningitis

CDC : 3 Bacterial meningitis is very serious and can be deadly. Death can occur in as little as a few hours. Most people recover from meningitis. However, permanent disabilities (such as brain damage, hearing loss, and learning disabilities) can result from the infection.

MalaCards based summary : Bacterial Meningitis, also known as meningitis, bacterial, is related to streptococcal meningitis and viral meningitis. An important gene associated with Bacterial Meningitis is CRP (C-Reactive Protein), and among its related pathways/superpathways are Innate Immune System and Akt Signaling. The drugs Dexamethasone acetate and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and spinal cord, and related phenotypes are homeostasis/metabolism and cardiovascular system

Disease Ontology : 12 A meningitis that has material basis in a bacterial infection.

Wikipedia : 77 Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord,... more...

Related Diseases for Bacterial Meningitis

Diseases in the Meningitis family:

Viral Meningitis Chronic Meningitis
Bacterial Meningitis

Diseases related to Bacterial Meningitis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 469, show less)
# Related Disease Score Top Affiliating Genes
1 streptococcal meningitis 32.9 CFP CRP TNF
2 viral meningitis 32.4 CRP CXCL8 IL6
3 aseptic meningitis 32.4 CXCL8 IL10 IL1B TNF
4 cerebral palsy 31.3 IL1B IL6 MMP8 TNF
5 meningitis 31.1 CFP CRP CXCL8 IL10 IL1B IL6
6 haemophilus influenzae 31.0 CXCL8 IL1B TLR2 TNF
7 tuberculous meningitis 30.5 CXCL8 MMP9 TLR2 TNF
8 brain injury 30.5 IL10 IL6 S100B
9 crohn's disease 30.2 CRP IL10 TLR9 TNF
10 neisseria meningitidis infection 30.1 CFP TLR2 TLR4
11 acute cystitis 30.1 CRP CXCL8 IL6
12 brain edema 30.1 IL1B IL6 MMP9
13 diverticulitis 30.1 CRP MMP9 TNF
14 traumatic brain injury 30.0 IL10 IL6 S100B
15 hematopoietic stem cell transplantation 29.9 IL10 IL6 TNF
16 apnea, obstructive sleep 29.9 CRP IL6 TNF
17 cholangitis 29.9 CRP IL6 TNF
18 infective endocarditis 29.8 CRP IL6 TLR2 TNF
19 scrub typhus 29.8 CRP IL10 IL1B TLR2 TLR4 TNF
20 septic arthritis 29.7 CRP CXCL8 TLR2 TLR4 TLR9
21 reactive arthritis 29.7 CRP IL10 MMP8 TNF
22 arthritis 29.7 CXCL8 IL10 IL1B IL6 MMP9 TNF
23 suppurative otitis media 29.6 CRP IL1B TLR2 TLR4 TLR9
24 myeloma, multiple 29.5 CRP CXCL8 IL6 TLR9 TNF
25 otitis media 29.5 CXCL8 IL10 IL1B IL6 TLR2 TLR4
26 tonsillitis 29.4 CXCL8 IL1B IL6 TLR9 TNF
27 osteomyelitis 29.4 CXCL8 IL10 IL1B IL6 TNF
28 endocarditis 29.4 CRP CXCL8 IL10 IL6 PIK3C2A TLR2
29 human immunodeficiency virus infectious disease 29.4 IL10 IL6 S100B TLR9 TNF
30 pertussis 29.3 IL10 IL1B IL6 TLR4 TNF
31 common variable immunodeficiency 29.3 IL10 IL6 TLR2 TLR9 TNF
32 multiple sclerosis 29.2 IL10 IL1B IL6 MMP9 PTGDS TNF
33 sleep apnea 29.1 CRP CXCL8 IL1B IL6 S100B TNF
34 peritonitis 29.0 CRP CXCL8 IL10 IL1B IL6 TLR2
35 diabetes mellitus 28.9 CRP IL1B IL6 PIK3C2A PTGDS TNF
36 human immunodeficiency virus type 1 28.6 CFP CR1 IL10 IL6 S100B TNF
37 systemic lupus erythematosus 28.5 CR1 CRP IL10 IL1B IL6 TLR2
38 pneumonia 28.5 CRP CXCL8 IL10 IL1B IL6 PIK3C2A
39 bacterial infectious disease 28.4 CFP CRP CXCL8 IL10 IL1B IL6
40 malaria 28.3 CR1 CRP CXCL8 IL10 IL1B IL6
41 haemophilus meningitis 11.7
42 meningococcal infection 11.6
43 meningococcal meningitis 11.1
44 syphilitic meningitis 11.1
45 listeria meningitis 11.1
46 pneumococcal meningitis 10.8
47 staphylococcal toxic shock syndrome 10.5 IL1B TNF
48 endomyocardial fibrosis 10.5 IL10 TNF
49 multifocal choroiditis 10.5 IL10 TNF
50 punctate inner choroidopathy 10.5 IL10 TNF
51 tropical endomyocardial fibrosis 10.5 IL10 TNF
52 drug reaction with eosinophilia and systemic symptoms 10.5 CRP TNF
53 myasthenic syndrome, congenital, 1a, slow-channel 10.5 CRP CXCL8
54 mycobacterium chelonae 10.5 CXCL8 TLR2
55 mycobacterium kansasii 10.5 CXCL8 TLR2
56 mycobacterium marinum 10.5 CXCL8 TLR2
57 chronic follicular conjunctivitis 10.5 IL1B MMP9
58 autoimmune inner ear disease 10.5 MMP9 TNF
59 vibratory urticaria 10.5 CXCL8 MMP9
60 amaurosis fugax 10.4 MMP8 MMP9
61 autoimmune uveitis 10.4 IL10 IL1B TNF
62 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.4
63 leprosy 3 10.4 IL10 TLR2 TNF
64 congenital cytomegalovirus 10.4 IL1B TLR2 TNF
65 familial mediterranean fever 10.4 CRP IL1B TNF
66 viral hepatitis 10.4 TLR2 TLR9 TNF
67 lentigo maligna melanoma 10.4 MMP9 S100B
68 lepromatous leprosy 10.4 IL10 TLR2 TNF
69 palindromic rheumatism 10.4 CRP IL1B TNF
70 extrapulmonary tuberculosis 10.4 IL10 IL1B TLR2
71 testicular disease 10.4 IL10 TLR2 TNF
72 pleural disease 10.4 CRP IL1B TNF
73 silicosis 10.4 CXCL8 IL1B TNF
74 crohn's colitis 10.4 CXCL8 IL1B TNF
75 coccidiosis 10.4 IL10 TLR9 TNF
76 opisthorchiasis 10.4 CXCL8 IL1B TNF
77 duodenal ulcer 10.4 CXCL8 IL1B TNF
78 angioimmunoblastic lymphadenopathy with dysproteinemia 10.4 IL6 TNF
79 critical limb ischemia 10.4 IL6 TNF
80 parasitic helminthiasis infectious disease 10.4 IL10 TLR9 TNF
81 juvenile ankylosing spondylitis 10.4 IL6 TNF
82 mucocutaneous leishmaniasis 10.4 IL10 TLR9 TNF
83 filarial elephantiasis 10.4 IL10 TLR2 TLR9
84 irritable bowel syndrome 10.4 IL10 TLR9 TNF
85 dental pulp disease 10.4 CXCL8 IL1B TNF
86 atrophic gastritis 10.4 CXCL8 IL1B TNF
87 lymphatic system disease 10.4 CRP TLR9 TNF
88 genital herpes 10.4 IL10 TLR2 TLR9
89 mycobacterium abscessus 10.4 CXCL8 TLR2 TNF
90 clonorchiasis 10.4 CXCL8 IL10 TNF
91 autoimmune myocarditis 10.4 IL6 TNF
92 leukomalacia 10.4 IL6 TNF
93 pleurisy 10.4 CRP CXCL8 TNF
94 scorpion envenomation 10.4 IL6 TNF
95 severe acute respiratory syndrome 10.4 CRP CXCL8 TNF
96 bronchitis 10.4 CRP CXCL8 TNF
97 pharyngitis 10.4 CRP CXCL8 IL1B
98 relapsing-remitting multiple sclerosis 10.3 IL10 MMP9 TNF
99 wells syndrome 10.3 CRP CXCL8 IL1B
100 penicilliosis 10.3 TLR2 TLR4 TNF
101 keratoconjunctivitis 10.3 CXCL8 TLR9 TNF
102 cold agglutinin disease 10.3 CRP IL6
103 cryopyrin-associated periodic syndrome 10.3 CRP IL6
104 alveolar echinococcosis 10.3 TLR2 TLR4 TNF
105 pyoderma 10.3 CXCL8 MMP9 TNF
106 diabetic foot ulcers 10.3 IL6 MMP9
107 bronchiectasis 10.3 CXCL8 MMP8 TLR2
108 spondyloarthropathy 1 10.3 CRP TLR4 TNF
109 spondylarthropathy 10.3 TLR2 TLR4 TNF
110 exudative glomerulonephritis 10.3 CXCL8 IL1B TNF
111 carotid artery disease 10.3 CRP MMP8 MMP9
112 secondary progressive multiple sclerosis 10.3 IL10 MMP9 S100B
113 joint disorders 10.3 IL1B IL6 TNF
114 chikungunya 10.3 IL1B IL6 TNF
115 dengue shock syndrome 10.3 IL1B IL6 TNF
116 pulmonary tuberculosis 10.3 IL10 TLR2 TLR9 TNF
117 endometritis 10.3 IL1B IL6 TNF
118 poems syndrome 10.3 IL1B IL6 TNF
119 glossitis 10.3 IL1B IL6 TNF
120 laryngitis 10.2 IL1B IL6 TNF
121 acute vascular insufficiency of intestine 10.2 IL1B IL6 TNF
122 dry eye syndrome 10.2 IL6 TLR9 TNF
123 osteosclerotic myeloma 10.2 IL1B IL6 TNF
124 hydrocephalus 10.2
125 dermatitis, atopic 10.2 CXCL8 IL10 TLR9 TNF
126 post-transplant lymphoproliferative disease 10.2 IL10 IL6 TNF
127 rheumatic heart disease 10.2 IL10 IL6 TNF
128 stachybotrys chartarum 10.2 IL1B IL6 TNF
129 skin disease 10.2 CXCL8 IL10 TLR9 TNF
130 spondyloarthropathy 10.2 IL10 IL6 TNF
131 temporal arteritis 10.2 CRP IL6 TNF
132 intermediate uveitis 10.2 IL10 IL6 TNF
133 peripheral nervous system disease 10.2 IL6 TLR9 TNF
134 plasmodium vivax malaria 10.2 IL10 IL6 TNF
135 end stage renal failure 10.2 CRP IL6 TNF
136 ischemic heart disease 10.2 CRP IL6 TNF
137 rheumatic fever 10.2 IL10 IL6 TNF
138 leukocyte disease 10.2 IL6 TLR9 TNF
139 mixed connective tissue disease 10.2 IL10 IL6 TNF
140 vibrio vulnificus infection 10.2 IL6 PIK3C2A
141 pancreas disease 10.2 CRP IL6 TNF
142 purpura 10.2 CRP IL6 TNF
143 meconium aspiration syndrome 10.2 CXCL8 IL6 TNF
144 overnutrition 10.2 CRP IL6 TNF
145 spondylitis 10.2 CRP IL6 TNF
146 newborn respiratory distress syndrome 10.2 CXCL8 IL1B IL6
147 demyelinating disease 10.2 IL10 IL1B MMP9 TNF
148 mesenteric lymphadenitis 10.2 CRP IL6 TLR2
149 tungiasis 10.2 CXCL8 IL10 TNF
150 esophagitis 10.2 CXCL8 IL1B IL6
151 vaginal disease 10.2 CXCL8 IL1B IL6
152 avian influenza 10.2 CXCL8 IL6 TNF
153 vaginitis 10.2 CXCL8 IL1B IL6
154 mastitis 10.2 CXCL8 IL6 TLR2
155 prosthetic joint infection 10.2 IL1B TLR2 TLR4
156 endometriosis 10.2 CXCL8 IL1B IL6
157 primary systemic mycosis 10.2 IL10 IL1B TLR2 TNF
158 fasciitis 10.2 CXCL8 IL6 TNF
159 multicentric castleman disease 10.2 CRP IL10 IL6
160 uremic pruritus 10.2 CRP IL1B IL6
161 gingival disease 10.2 IL1B IL6 MMP8
162 collagen disease 10.2 CRP IL6 TLR9
163 encephalitis 10.2
164 intervertebral disc disease 10.2 IL1B IL6 MMP9
165 cryptogenic organizing pneumonia 10.2 CXCL8 MMP9 PIK3C2A
166 trench fever 10.2 TLR2 TLR4 TNF
167 legionnaires' disease 10.2 PIK3C2A TLR4 TLR9
168 radiculopathy 10.2 CXCL8 IL10 IL6
169 mondini dysplasia 10.2
170 opportunistic mycosis 10.2 IL10 TLR2 TLR9 TNF
171 tropical spastic paraparesis 10.2 IL10 IL6 MMP9
172 cysticercosis 10.2 IL1B IL6 TLR4
173 aortic disease 10.2 CRP IL6 MMP9
174 sensorineural hearing loss 10.1
175 peptic ulcer disease 10.1 CXCL8 IL10 IL1B TNF
176 cystic echinococcosis 10.1 IL10 IL6 TLR4
177 nose disease 10.1 CXCL8 IL10 TLR9 TNF
178 bacteriuria 10.1 CXCL8 IL6 TLR4
179 crimean-congo hemorrhagic fever 10.1 IL6 PIK3C2A TNF
180 sudden infant death syndrome 10.1 IL10 IL1B IL6 TNF
181 allergic contact dermatitis 10.1 CXCL8 IL10 IL1B TNF
182 psoriatic arthritis 10.1 CRP IL1B IL6 TNF
183 respiratory failure 10.1 CRP CXCL8 PIK3C2A TNF
184 noonan syndrome 1 10.1 CXCL8 IL1B IL6 TNF
185 acquired immunodeficiency syndrome 10.1 IL10 IL1B IL6 TNF
186 recurrent corneal erosion 10.1 CXCL8 IL1B IL6
187 angina pectoris 10.1 CRP IL6 PIK3C2A
188 immune system disease 10.1 IL10 IL6 TLR9 TNF
189 connective tissue disease 10.1 IL10 IL6 TLR9 TNF
190 pericardial effusion 10.1 CRP IL6 PIK3C2A
191 urinary system disease 10.1 CRP IL6 TLR9 TNF
192 fatty liver disease 10.1 CXCL8 IL1B IL6 TNF
193 coronary stenosis 10.1 CRP IL6 PIK3C2A
194 bagassosis 10.1 CXCL8 IL1B IL6
195 intermediate coronary syndrome 10.1 CRP IL6 PIK3C2A
196 stroke, ischemic 10.1
197 obstructive hydrocephalus 10.1
198 pleural empyema 10.1
199 intracranial hypertension 10.1
200 invasive aspergillosis 10.1 CXCL8 TLR2 TLR4 TLR9
201 pouchitis 10.1 CXCL8 IL10 TLR4
202 eye lymphoma 10.1 IL10 IL6 TLR9
203 periodontosis 10.1 CXCL8 MMP9 TLR4 TNF
204 gastrointestinal system cancer 10.0 IL6 MMP9 TLR9 TNF
205 primary progressive multiple sclerosis 10.0 IL10 MMP9 S100B TNF
206 autoimmune gastritis 10.0 IL10 IL1B IL6 TNF
207 rheumatic disease 10.0 CRP IL10 IL1B TLR9 TNF
208 streptococcal toxic-shock syndrome 10.0 CXCL8 IL6 TNF
209 fungal keratitis 10.0 MMP8 MMP9 TLR2 TLR4
210 eales disease 10.0 IL10 IL1B IL6 TNF
211 acute pancreatitis 10.0 CRP CXCL8 IL10 IL6
212 carotid stenosis 10.0 CRP MMP9 S100B TNF
213 pelvic inflammatory disease 10.0 CRP MMP9 TLR2 TLR4
214 autoimmune disease of eyes, ear, nose and throat 10.0 IL10 IL6 TLR9 TNF
215 commensal bacterial infectious disease 10.0 IL10 IL1B IL6 TNF
216 pituitary apoplexy 10.0
217 epidural abscess 10.0
218 subdural empyema 10.0
219 head injury 10.0
220 headache 10.0
221 complex regional pain syndrome 10.0 IL10 IL1B IL6 TNF
222 periodontitis, chronic 10.0 IL1B IL6 MMP8 TLR2
223 atherosclerosis susceptibility 10.0 CRP IL6 TLR4 TNF
224 adult-onset still's disease 10.0 CRP IL1B IL6 TNF
225 hemophagocytic lymphohistiocytosis 10.0 CR1 CXCL8 IL10 TNF
226 hypersensitivity reaction type iii disease 10.0 CRP IL6 TLR9 TNF
227 pulpitis 10.0 CXCL8 IL1B IL6 TNF
228 stomach disease 10.0 CXCL8 IL1B MMP9 TLR9
229 exanthem 10.0 CRP IL6 TLR9 TNF
230 louse-borne relapsing fever 10.0 CRP CXCL8 IL6 TNF
231 acute respiratory distress syndrome 10.0 CXCL8 IL1B IL6 TNF
232 uveal disease 10.0 IL10 IL6 TLR9 TNF
233 cutaneous leishmaniasis 10.0 IL10 TLR2 TLR4 TLR9 TNF
234 pericarditis 10.0 CRP IL1B IL6 TNF
235 aspergillosis 10.0 IL10 TLR2 TLR4 TLR9 TNF
236 myositis fibrosa 10.0 PIK3C2A TLR2 TLR4 TLR9
237 salmonellosis 10.0 CKB IL1B TLR4
238 lymphadenitis 10.0 CXCL8 IL10 IL1B TLR4 TNF
239 mycobacterium tuberculosis 1 10.0 IL10 TLR2 TLR4 TLR9 TNF
240 hemorrhagic fever with renal syndrome 10.0 CRP CXCL8 IL6 TNF
241 chronic mucocutaneous candidiasis 10.0 IL10 IL1B IL6 TNF
242 acute pyelonephritis 10.0 CRP CXCL8 IL10 IL6
243 pneumoconiosis 10.0 CXCL8 IL1B IL6 TNF
244 bacterial sepsis 10.0 CRP CXCL8 IL10 TLR4 TNF
245 ocular motor apraxia 10.0
246 sinusitis 10.0
247 epidemic typhus 10.0
248 thrombosis 10.0
249 meningocele 10.0
250 cauda equina syndrome 10.0
251 myelitis 10.0
252 endophthalmitis 10.0
253 lupus erythematosus 10.0
254 congenital hydrocephalus 10.0
255 encephalocele 10.0
256 febrile seizures 10.0
257 acute transverse myelitis 10.0 CXCL8 IL10 IL6 MMP9
258 adult respiratory distress syndrome 10.0 CXCL8 IL10 IL6 TNF
259 dengue hemorrhagic fever 10.0 CXCL8 IL10 IL6 TNF
260 keratitis, hereditary 10.0 IL1B MMP9 TLR2 TLR4 TLR9
261 vascular disease 9.9 CRP IL6 MMP9 TNF
262 ileitis 9.9 IL6 TLR2 TLR4 TNF
263 placenta disease 9.9 CXCL8 IL1B IL6 TLR9
264 obstructive jaundice 9.9 CRP CXCL8 IL6 TNF
265 chronic fatigue syndrome 9.9 IL10 IL1B IL6 TNF
266 extrinsic allergic alveolitis 9.9 CXCL8 IL10 IL1B IL6
267 aphthous stomatitis 9.9 IL10 IL1B IL6 TLR2 TNF
268 lacrimal apparatus disease 9.9 IL10 IL1B IL6 TLR9 TNF
269 keratoconjunctivitis sicca 9.9 IL10 IL1B IL6 TLR9 TNF
270 alcoholic hepatitis 9.9 CXCL8 IL10 IL6 TNF
271 central nervous system vasculitis 9.9 CRP IL1B IL6 TLR9 TNF
272 autoimmune disease 9.9 IL10 IL1B IL6 TLR9 TNF
273 autoimmune disease of central nervous system 9.9 IL10 IL1B IL6 TLR9 TNF
274 periapical periodontitis 9.9 IL1B IL6 MMP8 TLR2 TNF
275 mycoplasma pneumoniae pneumonia 9.9 CRP IL10 IL6 TLR2 TNF
276 pyelitis 9.9 CRP CXCL8 IL6 TLR4
277 viral encephalitis 9.9 CXCL8 IL10 IL1B IL6 TNF
278 cytomegalovirus infection 9.9 CXCL8 IL1B IL6 TNF
279 glucose metabolism disease 9.9 CRP IL1B IL6 TLR9 TNF
280 prostatitis 9.9 CXCL8 IL10 IL1B IL6 TNF
281 acquired metabolic disease 9.9 CRP IL1B IL6 TLR9 TNF
282 spinal cord injury 9.9 CXCL8 IL6 MMP9 TNF
283 juvenile rheumatoid arthritis 9.9 CRP IL1B IL6 TNF
284 pulmonary fibrosis, idiopathic 9.9 CXCL8 IL1B MMP9 TLR9 TNF
285 cardiogenic shock 9.9 IL6 PIK3C2A TNF
286 contact dermatitis 9.9 CXCL8 IL10 IL1B IL6 TNF
287 autoimmune disease of musculoskeletal system 9.9 CRP IL10 IL6 TLR9 TNF
288 takayasu arteritis 9.9 CRP IL6 MMP9 TNF
289 esophageal cancer 9.9 CRP CXCL8 IL6 MMP9 TNF
290 leishmaniasis 9.9 IL10 IL1B TLR2 TLR4 TLR9 TNF
291 mycetoma 9.9 CR1 CXCL8 IL10 MMP9
292 ewing sarcoma 9.9 IL1B IL6 MMP9 S100B TNF
293 synovitis 9.9 CRP CXCL8 IL1B IL6 TNF
294 crouzon syndrome 9.9
295 intussusception 9.9
296 currarino syndrome 9.9
297 torticollis 9.9
298 polysubstance abuse 9.9
299 nasopharyngeal carcinoma 9.9
300 liver cirrhosis 9.9
301 cerebral arteritis 9.9
302 cortical blindness 9.9
303 arachnoiditis 9.9
304 cerebritis 9.9
305 cranial nerve palsy 9.9
306 intracranial thrombosis 9.9
307 hyperglycemia 9.9
308 measles 9.9
309 meningoencephalocele 9.9
310 meningitis and encephalitis 9.9
311 encephalopathy 9.9
312 fungal meningitis 9.9
313 cardiac arrest 9.9 CKB PIK3C2A S100B
314 glomerulonephritis 9.9 CFP CR1 IL1B TLR9
315 funisitis 9.9 CXCL8 IL10 IL1B IL6 MMP8
316 rosacea 9.8 IL6 MMP8 MMP9 TLR2 TNF
317 visceral leishmaniasis 9.8 CXCL8 IL10 TLR2 TLR4 TLR9 TNF
318 idiopathic neutropenia 9.8 IL10 IL1B IL6 TLR4 TNF
319 scabies 9.8 CFP CXCL8 IL10
320 transverse myelitis 9.8 CXCL8 IL10 IL6 MMP9 TNF
321 paracoccidioidomycosis 9.8 IL10 IL6 TLR2 TLR4 TNF
322 graft-versus-host disease 9.8 IL10 IL1B IL6 TNF
323 echinococcosis 9.8 IL10 IL6 TLR2 TLR4 TNF
324 melioidosis 9.8 IL10 IL6 TLR2 TLR4 TNF
325 endometrial disease 9.8 CXCL8 IL1B IL6 TLR4 TNF
326 typhoid fever 9.8 CRP IL1B IL6 TLR4 TNF
327 neurosyphilis 9.8 CXCL8 IL10 TLR2
328 female reproductive system disease 9.8 CXCL8 IL6 MMP9 TLR9 TNF
329 reproductive system disease 9.8 CXCL8 IL6 MMP9 TLR9 TNF
330 kawasaki disease 9.8 CRP IL10 IL6 MMP9 TNF
331 central nervous system disease 9.8 IL1B IL6 MMP9 TLR9 TNF
332 parasitic protozoa infectious disease 9.8 IL10 IL1B IL6 TLR2 TLR9 TNF
333 pulmonary edema 9.8 CRP CXCL8 IL10 IL1B PIK3C2A TNF
334 cystitis 9.8 CRP CXCL8 IL6 TLR4 TNF
335 viral pneumonia 9.8 CR1 CRP IL6 TLR9
336 lymph node disease 9.8 CRP IL10 IL1B IL6 TLR9 TNF
337 bacterial pneumonia 9.8 CRP CXCL8 IL6 TLR4 TLR9
338 dilated cardiomyopathy 9.8 CRP IL10 IL1B IL6 MMP9 TNF
339 upper respiratory tract disease 9.8 CXCL8 IL10 IL1B IL6 TLR9 TNF
340 bronchial disease 9.8 CXCL8 IL10 IL1B IL6 TLR9 TNF
341 castleman disease 9.8 CR1 CRP IL10 IL6
342 viral infectious disease 9.8 CXCL8 IL10 IL1B IL6 TLR9 TNF
343 gastroenteritis 9.8 CRP CXCL8 IL10 IL1B IL6 TNF
344 plasmodium falciparum malaria 9.7 CR1 IL10 TLR9 TNF
345 lyme disease 9.7 CRP IL1B IL6 MMP9 TLR2 TNF
346 monocytic leukemia 9.7 CXCL8 IL1B IL6 TNF
347 arteries, anomalies of 9.7 CRP IL1B IL6 MMP9 TLR9 TNF
348 cerebrovascular disease 9.7 CRP IL6 MMP9 TLR4 TNF
349 acute myocardial infarction 9.7 CKB CRP MMP9 PIK3C2A
350 q fever 9.7 IL10 IL1B IL6 TLR2 TLR4 TNF
351 alcohol dependence 9.7
352 attention deficit-hyperactivity disorder 9.7
353 small cell cancer of the lung 9.7
354 neural tube defects 9.7
355 spinal arachnoiditis 9.7
356 tetralogy of fallot 9.7
357 lung cancer 9.7
358 hydrocephalus, congenital, 1 9.7
359 l-2-hydroxyglutaric aciduria 9.7
360 pituitary hormone deficiency, combined, 2 9.7
361 pigmentary disorder, reticulate, with systemic manifestations, x-linked 9.7
362 ataxia and polyneuropathy, adult-onset 9.7
363 aging 9.7
364 pituitary adenoma, prolactin-secreting 9.7
365 brittle bone disorder 9.7
366 langerhans cell histiocytosis 9.7
367 allergic rhinitis 9.7
368 complement component 4b deficiency 9.7
369 blood group, junior system 9.7
370 leukemia 9.7
371 liver disease 9.7
372 neuromyelitis optica 9.7
373 pol iii-related leukodystrophies 9.7
374 thrombocytopenia 9.7
375 rocky mountain spotted fever 9.7
376 2-hydroxyglutaric aciduria 9.7
377 immunoglobulin alpha deficiency 9.7
378 ptosis 9.7
379 adenoid hypertrophy 9.7
380 mastoiditis 9.7
381 obstructive nephropathy 9.7
382 meningoencephalitis 9.7
383 sphenoid sinusitis 9.7
384 japanese encephalitis 9.7
385 discitis 9.7
386 spotted fever 9.7
387 horner's syndrome 9.7
388 quadriplegia 9.7
389 guillain-barre syndrome 9.7
390 dementia 9.7
391 uveitis 9.7
392 acute cholangitis 9.7
393 pyuria 9.7
394 status epilepticus 9.7
395 epilepsy 9.7
396 thrombocytosis 9.7
397 relapsing polychondritis 9.7
398 substance abuse 9.7
399 ischemia 9.7
400 inappropriate adh syndrome 9.7
401 histiocytosis 9.7
402 lactic acidosis 9.7
403 pituitary adenoma 9.7
404 thrombophlebitis 9.7
405 rhinitis 9.7
406 movement disease 9.7
407 benign ependymoma 9.7
408 complement deficiency 9.7
409 adenoma 9.7
410 influenza 9.7
411 vasculitis 9.7
412 chickenpox 9.7
413 col1a1/2-related osteogenesis imperfecta 9.7
414 sickle cell disease 9.7
415 anterior uveitis 9.7
416 brainstem auditory evoked responses 9.7
417 ependymoma 9.7
418 idiopathic hypertrophic pachymeningitis 9.7
419 neuromyelitis optica spectrum disorder 9.7
420 pineal cyst 9.7
421 seizure disorder 9.7
422 igg4-related pachymeningitis 9.7
423 cerebral visual impairment 9.7
424 neonatal meningitis 9.7
425 arteriosclerosis 9.7 CRP IL10 IL6 MMP9 TLR4
426 interstitial lung disease 9.7 CXCL8 IL10 IL1B IL6 MMP9 TNF
427 filariasis 9.7 IL10 IL6 TLR2 TLR4 TLR9 TNF
428 bacterial vaginosis 9.7 CXCL8 IL1B IL6 TLR2 TLR4 TNF
429 pulmonary disease, chronic obstructive 9.7 CRP CXCL8 IL6 MMP9 TLR2 TNF
430 bronchiolitis obliterans 9.7 CXCL8 IL10 IL6 MMP8 MMP9 TNF
431 brucellosis 9.7 CRP CXCL8 IL10 IL6 TLR4 TNF
432 preterm premature rupture of the membranes 9.7 CRP CXCL8 IL1B IL6 MMP8 MMP9
433 trypanosomiasis 9.6 CXCL8 IL10 IL1B IL6 TLR2 TLR9
434 bone inflammation disease 9.6 CRP CXCL8 IL10 IL1B IL6 TLR9
435 toxoplasmosis 9.6 IL10 IL1B IL6 TLR2 TLR4 TLR9
436 middle ear disease 9.6 CXCL8 IL1B IL6 TLR2 TLR4 TLR9
437 gingivitis 9.6 CXCL8 IL1B IL6 MMP8 MMP9 TLR2
438 muscular disease 9.6 CRP IL6 PIK3C2A TLR9 TNF
439 toxic shock syndrome 9.6 CXCL8 IL10 IL1B IL6 TLR2 TLR4
440 chagas disease 9.6 CXCL8 IL10 IL1B IL6 TLR2 TLR4
441 colitis 9.6 CXCL8 IL10 IL1B IL6 TLR4 TLR9
442 perinatal necrotizing enterocolitis 9.6 CRP CXCL8 IL1B IL6 TLR4 TLR9
443 legionellosis 9.6 CR1 IL1B PIK3C2A TLR2 TLR4 TNF
444 pyelonephritis 9.5 CRP CXCL8 IL10 IL1B IL6 TLR4
445 ulcerative colitis 9.5 CRP CXCL8 IL10 IL1B IL6 TLR4
446 bronchiolitis 9.5 CRP CXCL8 IL10 IL6 TLR4 TLR9
447 aggressive periodontitis 9.5 CXCL8 IL10 IL1B IL6 MMP8 TLR4
448 large intestine cancer 9.4 CRP CXCL8 IL10 IL1B IL6 MMP9
449 asthma 9.4 CXCL8 IL10 IL1B IL6 MMP9 TLR9
450 chlamydia 9.4 CRP CXCL8 IL10 IL1B IL6 TLR2
451 inflammatory bowel disease 9.4 CRP CXCL8 IL10 IL1B IL6 TLR2
452 intestinal disease 9.4 CRP CXCL8 IL10 IL1B IL6 TLR4
453 appendicitis 9.4 CRP CXCL8 IL10 IL1B IL6 MMP8
454 behcet syndrome 9.4 CRP CXCL8 IL10 IL1B IL6 TLR4
455 nervous system disease 9.4 CRP IL10 IL1B IL6 MMP9 S100B
456 mouth disease 9.4 CRP IL10 IL1B IL6 MMP8 TLR4
457 leptospirosis 9.4 CRP CXCL8 IL10 IL1B IL6 PIK3C2A
458 chorioamnionitis 9.3 CRP CXCL8 IL1B IL6 MMP8 MMP9
459 extrinsic cardiomyopathy 9.3 CRP IL10 IL1B IL6 PIK3C2A TLR4
460 lung disease 9.3 CXCL8 IL10 IL1B IL6 MMP8 MMP9
461 primary bacterial infectious disease 9.3 CRP CXCL8 IL10 IL1B IL6 TLR2
462 heart disease 9.3 CRP CXCL8 IL10 IL1B IL6 PIK3C2A
463 proteasome-associated autoinflammatory syndrome 1 9.2 CRP CXCL8 IL10 IL1B IL6 MMP9
464 respiratory system disease 9.2 CRP CXCL8 IL10 IL1B IL6 MMP9
465 gastrointestinal system disease 9.2 CRP CXCL8 IL10 IL1B IL6 MMP9
466 rheumatoid arthritis 9.2 CRP CXCL8 IL10 IL1B IL6 MMP9
467 periodontal disease 9.2 CRP CXCL8 IL1B IL6 MMP8 MMP9
468 periodontitis 8.9 CRP CXCL8 IL10 IL1B IL6 MMP8
469 myocardial infarction 8.6 CKB CRP IL10 IL1B IL6 MMP9

Comorbidity relations with Bacterial Meningitis via Phenotypic Disease Network (PDN): (showing 1, show less)


Acute Cystitis

Graphical network of the top 20 diseases related to Bacterial Meningitis:



Diseases related to Bacterial Meningitis

Symptoms & Phenotypes for Bacterial Meningitis

MGI Mouse Phenotypes related to Bacterial Meningitis:

47 (showing 10, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.21 CFP CRP IL10 IL1B IL6 MMP8
2 cardiovascular system MP:0005385 10.16 CFP CRP IL10 IL1B IL6 MMP9
3 behavior/neurological MP:0005386 10.13 CKB IL10 IL6 MMP9 PTGDS S100B
4 immune system MP:0005387 10.13 CFP CRP IL10 IL1B IL6 MMP8
5 hematopoietic system MP:0005397 10.1 IL10 IL1B IL6 MMP9 PIK3C2A PTGDS
6 digestive/alimentary MP:0005381 9.98 IL10 IL6 MMP9 TLR2 TLR4 TLR9
7 integument MP:0010771 9.91 IL10 IL1B IL6 MMP9 PTGDS S100B
8 neoplasm MP:0002006 9.81 IL10 IL1B IL6 MMP8 MMP9 PTGDS
9 nervous system MP:0003631 9.61 CKB IL10 IL1B IL6 MMP9 PTGDS
10 skeleton MP:0005390 9.28 CFP IL10 IL1B IL6 MMP9 PTGDS

Drugs & Therapeutics for Bacterial Meningitis

Drugs for Bacterial Meningitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 217, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 1177-87-3
2
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 50-02-2 5743
3
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
4
Cefotaxime Approved Phase 4,Phase 2 63527-52-6 5742673 456256
5
Cefoxitin Approved Phase 4,Phase 2 35607-66-0 441199
6
Acetaminophen Approved Phase 4,Phase 3 103-90-2 1983
7
Ceftriaxone Approved Phase 4,Phase 3,Phase 1 73384-59-5 5479530 5361919
8
Azathioprine Approved Phase 4 446-86-6 2265
9
Ciprofloxacin Approved, Investigational Phase 4,Early Phase 1,Not Applicable 85721-33-1 2764
10
Amikacin Approved, Investigational, Vet_approved Phase 4 37517-28-5 37768
11 Antineoplastic Agents, Hormonal Phase 4,Phase 2,Phase 3
12 BB 1101 Phase 4,Phase 2,Phase 3
13 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2
14 Gastrointestinal Agents Phase 4,Phase 3,Phase 2
15 Antiemetics Phase 4,Phase 2,Phase 3
16 glucocorticoids Phase 4,Phase 2,Phase 3
17 Autonomic Agents Phase 4,Phase 2,Phase 3
18 Hormone Antagonists Phase 4,Phase 2,Phase 3
19 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 3
20
protease inhibitors Phase 4,Phase 2,Phase 3
21 HIV Protease Inhibitors Phase 4,Phase 2,Phase 3
22 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 3
23 Hormones Phase 4,Phase 2,Phase 3
24 Anticonvulsants Phase 4
25 Sodium Channel Blockers Phase 4
26 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
27 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
28 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
29 Diuretics, Potassium Sparing Phase 4
30 Immunoglobulins Phase 4,Phase 3,Phase 2,Not Applicable
31 Vaccines Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
32 Antibodies Phase 4,Phase 3,Phase 2,Not Applicable
33 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
34 Immunoglobulins, Intravenous Phase 4,Phase 3,Phase 2,Not Applicable
35 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 1,Phase 2,Not Applicable
36 Analgesics Phase 4,Phase 3,Phase 2
37 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2
38 beta-Lactams Phase 4
39 Antipyretics Phase 4,Phase 3,Phase 2
40 Lactams Phase 4
41 Gentamicins Phase 4,Phase 3
42 penicillins Phase 4,Phase 3
43 Heptavalent Pneumococcal Conjugate Vaccine Phase 4,Phase 3,Phase 2
44 Antirheumatic Agents Phase 4,Phase 2
45 Antimetabolites Phase 4,Not Applicable
46 Immunosuppressive Agents Phase 4
47 Antimetabolites, Antineoplastic Phase 4
48 gamma-Globulins Phase 4,Phase 3,Phase 2,Not Applicable
49 Rho(D) Immune Globulin Phase 4,Phase 3,Phase 2,Not Applicable
50 Cytochrome P-450 CYP1A2 Inhibitors Phase 4,Phase 1,Phase 2
51 Topoisomerase Inhibitors Phase 4,Phase 2,Phase 1
52 Neuromuscular Blocking Agents Phase 4
53
Glycerol Approved, Investigational Phase 3,Early Phase 1 56-81-5 753
54
Ethambutol Approved Phase 2, Phase 3,Phase 1 74-55-5 14052 3279
55
Rifampicin Approved Phase 2, Phase 3,Phase 1 13292-46-1 5381226 5458213
56
Pyrazinamide Approved, Investigational Phase 2, Phase 3,Phase 1 98-96-4 1046
57
Hydroxocobalamin Approved Phase 3,Phase 2 13422-51-0 15589840 11953898
58
Amoxicillin Approved, Vet_approved Phase 3,Phase 2 26787-78-0 33613
59
Aluminum hydroxide Approved, Investigational Phase 2, Phase 3 21645-51-2
60
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
61
tannic acid Approved Phase 3 1401-55-4
62
Metronidazole Approved Phase 3 443-48-1 4173
63
Procaine Approved, Investigational, Vet_approved Phase 3 59-46-1 4914
64
Ampicillin Approved, Vet_approved Phase 3 69-53-4 6249
65
Penicillin G Approved, Vet_approved Phase 3 61-33-6 5904
66
Proline Approved, Nutraceutical Phase 3 147-85-3 145742
67
Pyridoxine Approved, Investigational, Nutraceutical, Vet_approved Phase 2, Phase 3,Phase 3 65-23-6 1054
68
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2, Phase 3 59-30-3 6037
69
Cyanocobalamin Approved, Nutraceutical Phase 3,Phase 2 68-19-9 44176380
70
Lactitol Investigational Phase 3,Phase 2 585-88-6, 585-86-4 493591
71
Cobalamin Experimental Phase 3,Phase 2 13408-78-1 6857388
72 Cytochrome P-450 CYP3A Inducers Phase 2, Phase 3,Phase 1,Not Applicable
73 Vitamins Phase 2, Phase 3
74 Nucleic Acid Synthesis Inhibitors Phase 2, Phase 3,Phase 1,Not Applicable
75 Protective Agents Phase 3,Phase 2
76 Immunoglobulin G Phase 3,Phase 2
77 Pharmaceutical Solutions Phase 3,Phase 2,Phase 1,Early Phase 1
78 Laxatives Phase 3,Phase 2
79 Cathartics Phase 3,Phase 2
80 Vitamin B9 Phase 2, Phase 3
81 Antitubercular Agents Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
82 Trace Elements Phase 2, Phase 3
83 Folate Phase 2, Phase 3
84 Nutrients Phase 2, Phase 3
85 Micronutrients Phase 2, Phase 3
86 Vitamin B Complex Phase 2, Phase 3
87 Vitamin B 6 Phase 2, Phase 3
88 Vitamin B12 Phase 3,Phase 2
89 Vitamin B 12 Phase 3,Phase 2
90 Antacids Phase 2, Phase 3
91 Anti-Ulcer Agents Phase 2, Phase 3
92 Adjuvants, Immunologic Phase 2, Phase 3
93 Liver Extracts Phase 3
94 Cephalosporins Phase 3,Phase 2
95 Antiparasitic Agents Phase 3
96 Penicillin G Benzathine Phase 3
97 Antiprotozoal Agents Phase 3
98 Penicillin G Procaine Phase 3
99
Pyridoxal Experimental, Nutraceutical Phase 2, Phase 3 66-72-8 1050
100
Meropenem Approved, Investigational Phase 1, Phase 2 119478-56-7, 96036-03-2 441130 64778
101
Histamine Approved, Investigational Phase 2 51-45-6 774
102
Ranitidine Approved Phase 2 66357-59-3, 66357-35-5 3001055
103
Sodium Citrate Approved, Investigational Phase 2 68-04-2
104
Aluminum sulfate Approved Phase 2 10043-01-3
105
Aspirin Approved, Vet_approved Phase 2 50-78-2 2244